Position in LQDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,606,427
+$1,337,838 QoQ
Shares Held
45,233
-24.8% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#96
of 333 holders
Holding Since
Sep 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Derivatives in LQDA
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$3,587,850
PutShares
45,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $29,871,201 across 13 Drug Manufacturers - Specialty & Generic names. LQDA ranks #4 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
40,988 | $6,908,117 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
250,000 | $6,152,500 | |
| 3 | TRLV |
Trulieve Cannabis Corp.
|
500,000 | $4,915,000 | |
| 4 | LQDA |
Liquidia Corp
This page
|
45,233 | $3,606,427 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
97,363 | $3,375,575 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
3,675 | $1,991,225 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
15,000 | $1,664,100 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,500 | $479,625 |
All Filings in LQDA
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,606,427 | 45,233 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $3,587,850 | 45,000 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $2,268,589 | 60,111 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $1,887,000 | 50,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $2,586,750 | 75,000 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $2,586,750 | 75,000 | Put | Sole | 2026-02-13 | |
| 2025-09-30 | $1,830,024 | 80,476 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,495,200 | 120,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,475,000 | 100,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $460,878 | 31,246 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $406,660 | 34,580 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $169,284 | 14,107 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $183,226 | 28,900 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||